title: Locally delivered bisphosphonate for enhancement of bone formation and implant fixation.
authors.affiliation: Montreal General Hospital, Montreal, QC, Canada. john.bobyn@mcgill.ca
authors.forename: J Dennis
authors.initials: JD
authors.lastname: Bobyn
authors.forename: Kimberly
authors.initials: K
authors.lastname: McKenzie
authors.forename: Dorota
authors.initials: D
authors.lastname: Karabasz
authors.forename: Jan J
authors.initials: JJ
authors.lastname: Krygier
authors.forename: Michael
authors.initials: M
authors.lastname: Tanzer
mesh_terms: D000818:Animals; D001672:Biocompatible Materials; D050071:Bone Density Conservation Agents / Q000008:administration & dosage; D004164:Diphosphonates / Q000008:administration & dosage*; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D007093:Imidazoles / Q000008:administration & dosage*; D023421:Models, Animal; D016348:Osseointegration / Q000187:drug effects*; D010012:Osteogenesis / Q000187:drug effects*; D013635:Tantalum; D000077211:Zoledronic Acid
chemical_list: D001672:Biocompatible Materials; D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D013635:Tantalum; D000077211:Zoledronic Acid